PPARG and COVID-19: Accordingly, ASX-mediated activation of PPARγ has been proposed as an effective therapeutic strategy to control host inflammatory and immune responses, antagonize the cytokine storm, and prevent deleterious inflammatory effects following COVID-19 (191).